Literature DB >> 8408704

Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

S Nicholls1, S Stephens, C P Braegger, J A Walker-Smith, T T MacDonald.   

Abstract

AIMS: To determine the concentrations of interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF alpha) in stools from children.
METHODS: Stool samples from 14 healthy children, 32 children with inflammatory bowel disease, and 23 children with acute diarrhoea were emulsified in an equal volume of phosphate buffered saline and then centrifuged to produce a clear supernatant fluid. IL-6 and TNF alpha were measured by enzyme linked immunosorbent assay (ELISA).
RESULTS: TNF alpha was detected in the stools of all 14 healthy children (12-130 pg/g stool), but IL-6 was detected only in three. Similar results were seen in children with inactive inflammatory bowel disease. Stool TNF alpha concentrations were raised in samples from children with active inflammatory bowel disease, but in most (11/18) of these samples IL-6 was undetectable. Stool samples contained a heat-labile factor which rapidly destroyed IL-6 immunoreactivity. Most children with diarrhoea had TNF alpha concentrations similar to those of healthy controls and most were also negative for IL-6. Three children with Shigella flexneri infection had extraordinarily high concentrations of both TNF alpha and IL-6 in their stools.
CONCLUSIONS: There is constant low grade production of TNF alpha in the intestine of healthy people. Raised values are indicative of mucosal inflammation, but are not specific. Stool IL-6 is of little use in assessing mucosal inflammation because immunoreactivity is rapidly lost in stool samples.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408704      PMCID: PMC501465          DOI: 10.1136/jcp.46.8.757

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Enhanced mucosal cytokine production in inflammatory bowel disease.

Authors:  W E Pullman; S Elsbury; M Kobayashi; A J Hapel; W F Doe
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

2.  TNF alpha in stool as marker of intestinal inflammation.

Authors:  D G de Silva; L N Mendis; N Sheron; G J Alexander; D C Candy; H Chart; B Rowe
Journal:  Lancet       Date:  1992-08-08       Impact factor: 79.321

3.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

4.  Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.

Authors:  C Stevens; G Walz; C Singaram; M L Lipman; B Zanker; A Muggia; D Antonioli; M A Peppercorn; T B Strom
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

5.  Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha.

Authors:  D B Dubravec; D R Spriggs; J A Mannick; M L Rodrick
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

7.  Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.

Authors:  V Gross; T Andus; I Caesar; M Roth; J Schölmerich
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

8.  Tumour necrosis factor alpha in stool as a marker of intestinal inflammation.

Authors:  C P Braegger; S Nicholls; S H Murch; S Stephens; T T MacDonald
Journal:  Lancet       Date:  1992-01-11       Impact factor: 79.321

9.  Interleukin-6 and its receptor are expressed in human intestinal epithelial cells.

Authors:  K Shirota; L LeDuy; S Y Yuan; S Jothy
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

10.  O- and N-glycosylation lead to different molecular mass forms of human monocyte interleukin-6.

Authors:  V Gross; T Andus; J Castell; D Vom Berg; P C Heinrich; W Gerok
Journal:  FEBS Lett       Date:  1989-04-24       Impact factor: 4.124

View more
  30 in total

1.  Activation of nuclear factor kappaB as a target for anti-inflammatory therapy.

Authors:  S Schreiber
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

2.  Stool interleukin 1beta and interleukin 1 receptor antagonist concentrations in children with active ulcerative colitis and during recovery.

Authors:  Andrzej Wedrychowicz; Janina Stopyrowa; Krzysztof Fyderek; Witold Miezynski
Journal:  Eur J Pediatr       Date:  2003-04-26       Impact factor: 3.183

3.  Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.

Authors:  O Grip; S Janciauskiene; A Bredberg
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

4.  Human norovirus infection and the acute serum cytokine response.

Authors:  K L Newman; C L Moe; A E Kirby; W D Flanders; C A Parkos; J S Leon
Journal:  Clin Exp Immunol       Date:  2015-09-22       Impact factor: 4.330

5.  Activation of nuclear factor kappa B inflammatory bowel disease.

Authors:  S Schreiber; S Nikolaus; J Hampe
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

6.  Association between TNF-alpha and Entamoeba histolytica diarrhea.

Authors:  Kristine M Peterson; Jianfen Shu; Priya Duggal; Rashidul Haque; Dinesh Mondal; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

7.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice.

Authors:  Laura Harris; Patricia Senagore; Vincent B Young; Laura R McCabe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

9.  Antidepressants can treat inflammatory bowel disease through regulation of the nuclear factor-κB/nitric oxide pathway and inhibition of cytokine production: A hypothesis.

Authors:  Hamid Reza Rahimi; Mahdi Shiri; Ali Razmi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-12-06

10.  Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses.

Authors:  S Stephens; S Emtage; O Vetterlein; L Chaplin; C Bebbington; A Nesbitt; M Sopwith; D Athwal; C Novak; M Bodmer
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.